Upcoming ISG Provider Lens^® report will evaluate specialist providers helping life sciences enterprises accelerate innovation, improve patient outcomes

Information Services Group (ISG) (Nasdaq: III), a global AI-centered technology research and advisory firm, has launched a research study examining specialist providers of analytics and AI services that integrate data across research, clinical, commercial and post-market functions of the life sciences industry.

The study results will be published in a comprehensive ISG Provider Lens^® report, called Specialty Analytics and AI Services — Life Sciences, scheduled to be released in September 2026. The report will cover companies offering specialized analytics and AI services to life sciences enterprises, excluding platform vendors and large service providers.

Enterprise buyers will be able to use information from the report to evaluate their current vendor relationships, potential new engagements and available offerings, while ISG advisors use the information to recommend providers to the firm’s buy-side clients.

As data and AI become central to life sciences innovation and operations, enterprises are increasingly relying on specialist analytics and AI services providers to accelerate digital transformation. Organizations are applying next-generation analytics, including predictive modeling, to derisk drug discovery, optimize clinical trial design and execution, accelerate time to market and enhance sales effectiveness. Through advanced AI techniques such as GenAI and agentic AI, they are generating in-depth insights into disease progression, treatment effectiveness and safety, supporting more informed decision-making across R&D, clinical and commercial functions.

“Growing volumes of clinical and real-world data present a significant opportunity for life sciences enterprises, yet innovation must advance within strict privacy and compliance frameworks,” said Namratha Dharshan, chief business leader at ISG. “Specialist providers play a critical role in enabling secure, actionable analytics adoption that improves regulatory readiness, operational productivity and patient outcomes.”

ISG has distributed surveys to approximately 20 specialty analytics and AI service providers. Working in collaboration with ISG’s global advisors, the research team will produce one quadrant representing the analytics and AI services that typical life sciences enterprises are buying, based on ISG’s experience working with its clients. The quadrant is:

• Specialty Analytics and AI Services — Life Sciences, evaluating providers delivering custom analytics and AI solutions across the life sciences value chain. Providers are assessed on their ability to operationalize analytics at scale within highly regulated environments and demonstrate expertise spanning R&D analytics, clinical trials and pharmacovigilance.

The study will cover the global market for specialty analytics and AI services in the life sciences and examine products and services available globally. ISG analysts Manav Deep Sachdeva and Saravanan M S will serve as authors of the report.

A list of identified providers and vendors and further details on the study are available in this digital brochure. Companies not listed as specialty analytics and AI service providers for the life sciences industry can contact ISG and ask to be included in the study.

All 2026 ISG Provider Lens^® evaluations feature expanded customer experience (CX) data that measures actual enterprise experience with specific provider services and solutions, based on ISG’s continuous CX research.

About ISG Provider Lens^® Research

The ISG Provider Lens^® Quadrant research series is the only service provider evaluation of its kind to combine empirical, data-driven research and market analysis with the real-world experience and observations of ISG’s global advisory team. Enterprises will find a wealth of detailed data and market analysis to help guide their selection of appropriate sourcing partners, while ISG advisors use the reports to validate their own market knowledge and make recommendations to ISG’s enterprise clients. The research currently covers providers offering their services globally, across Europe, as well as in the U.S., Canada, Mexico, Brazil, the U.K., France, Benelux, Germany, Switzerland, the Nordics, Australia and Singapore/Malaysia, with additional markets to be added in the future. For more information about ISG Provider Lens research, please visit this webpage.

About ISG

ISG (Nasdaq: III) is a global AI-centered technology research and advisory firm. A trusted partner to more than 900 clients, including 75 of the world’s top 100 enterprises, ISG is a long-time leader in technology and business services that is now at the forefront of leveraging AI to help organizations achieve operational excellence and faster growth. The firm, founded in 2006, is known for its proprietary market data, in-depth knowledge of provider ecosystems, and the expertise of its 1,600 professionals worldwide working together to help clients maximize the value of their technology investments.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260219756105/en/

Growing volumes of clinical and real-world data present a significant opportunity for life sciences enterprises, yet companies face strict privacy and compliance requirements. Specialist providers play a critical role in enabling secure analytics adoption.